Rare diseases
Investigational molecules
Locations
Back to Poland2 clinical trials in Suwalki, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandPolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on hematologic malignancies, specifically investigating new therapeutic approaches for blood disorders.
The study evaluates a novel therapeutic agent RVU120 for patients with relapsed or refractory conditions, aiming to assess its anti-tumor activity in challenging blood cancer cases.
Clinical investigations centered on developing targeted therapies for patients with resistant blood cancers, particularly those who have not responded to previous treatments.
This multicenter trial represents an important step in expanding treatment options for patients with advanced hematologic conditions.
Research focused on understanding the role of genetic mutations in blood cancers and their impact on treatment outcomes.
The study aims to advance our understanding of targeted therapies in both mutation-positive and mutation-negative disease states.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
